Cargando…
Gamma tocotrienol targets tyrosine phosphatase SHP2 in mammospheres resulting in cell death through RAS/ERK pathway
BACKGROUND: There is increasing evidence supporting the concept of cancer stem cells (CSCs), which are responsible for the initiation, growth and metastasis of tumors. CSCs are thus considered the target for future cancer therapies. To achieve this goal, identifying potential therapeutic targets for...
Autores principales: | Gu, Wenyi, Prasadam, Indira, Yu, Meihua, Zhang, Fengxia, Ling, Patrick, Xiao, Yin, Yu, Chengzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552156/ https://www.ncbi.nlm.nih.gov/pubmed/26315028 http://dx.doi.org/10.1186/s12885-015-1614-1 |
Ejemplares similares
-
Regulation of autoimmune arthritis by the SHP-1 tyrosine phosphatase
por: Markovics, Adrienn, et al.
Publicado: (2020) -
Inhibition of SHP2 and SHP1 Protein Tyrosine Phosphatase
Activity by Chemically Induced Dimerization
por: Buck, Sara J. S., et al.
Publicado: (2022) -
Determination of the molecular reach of the protein tyrosine phosphatase SHP-1
por: Clemens, Lara, et al.
Publicado: (2021) -
Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
por: Song, Zhendong, et al.
Publicado: (2021) -
Tyrosine phosphatase SHP2 exacerbates psoriasis‐like skin inflammation in mice via ERK5‐dependent NETosis
por: Ding, Yan, et al.
Publicado: (2022)